Spring Clinical Conference

Proudly Presented by the

ARIZONA PHARMACY ASSOCIATION

February 21-23, 2020

Marriott Tucson University Park Hotel

880 E. Second Street | Tucson, AZ 85719

This 1.5 day seminar provides approximately (12.5) hours of continuing education for pharmacy professionals focusing on clinical topics pertinent to institutional and ambulatory care settings.

Tentative Agenda

FRIDAY, FEBRUARY 21st

7:00AM - 6:00PM | REGISTRATION DESK HOURS

 

7:30AM - 8:30AM | COFFEE

 

8:00AM - 5:00PM | AzPA ANTICOAGULATION CERTIFICATE PROGRAM

  • Lindsay Davis, PharmD, BCPS, FAzPA
  • Jason Gerstner, PharmD, BCPS, BCCCP
  • Elizabeth Pogge, PharmD, MPH, BCPS, FASCP

 

8:00AM - 5:00PM | APhA DELIVERING MEDICATION THERAPY MANAGEMENT CERTIFICATE PROGRAM

  • Jessica Dileo, PharmD, BCACP, BCGP
  • Andrew Lester, PharmD, MBA, BCACP

 

12:00PM - 1:00PM | LUNCH

 

 

SATURDAY, FEBRUARY 22nd

6:30AM - 5:00PM | REGISTRATION DESK HOURS

 

7:30AM - 8:30AM | CONTINENTAL BREAKFAST - CE Symposium:  Betting on BTK Inhibitors in CLL:  Where are We Now and Where are We Going?
Rebecca J. Nelson, PharmD, BCOP

Pharmacist learning objectives:

  • Describe the role of the BCR (B-cell receptor) pathway in malignant B-cell survival.
  • Explore the therapeutic rationale for targeting the BCR pathway in CLL and other B-cell malignancies.
  • Assess the latest safety and efficacy data for BTKis (BTK inhibitors) in TN (treatment-naïve) and R/R (relapsed/refractory) CLL and examine strategies to overcome resistance seen in these agents.
  • Using a case-based approach, appraise effective strategies to integrate BTK inhibitors into the CLL treatment paradigm, recognize and appropriately manage adverse events, and answer challenging clinical issues pharmacists may encounter in their practice.

UAN 0101-0000-20-001-L01-P (Pharmacist only – co-provided CPE activity)

 

8:30AM - 9:30AM | GENERAL SESSION I
Impact of Clinician Burnout on Patient Safety: Journey to a Resilient & Thriving Healthcare Workforce 
Hannah Vanderpool, PharmD, M.A.

Pharmacist/Pharmacy Technician learning objectives:

  • Review the causes of burnout and consequences for patient care providers and patients.
  • Describe the National Academy of Medicine Clinician Well-Being and Resilience Action Collaborative
  • Identify evidence-based systems interventions for patient care providers to mitigate risk.
  • Identify recommendations to impact well-being and resilience in pharmacists, pharmacy residents, student pharmacists and pharmacy technicians

UAN 0100-000-20-001-L05-P/T

 

9:45AM - 10:45AM | GENERAL SESSION II
Not Your Father’s Opioids:  2nd and 3rd Generation Drugs

Robert B. Raffa, Ph.D.

Pharmacist/Pharmacy Technician learning objectives:

  • Recognize that not all opioids work the same way.
  • List analgesic effects of opioids through four known receptors.
  • Describe how this translates into different efficacy and safety profiles
  • Describe the strategies of the 2nd and 3rd generation opioids

UAN 0100-0000-20-003-L08-P/T

 

11:00AM - 12:00PM | GENERAL SESSION III
Life in the Fast Lane: An exploration into time restricted eating, intermittent and extended fasting

Cory Jenks, PharmD, BCACP

Pharmacist/Pharmacy Technician learning objectives:

  • Define various types of fasting
  • Recall the proposed mechanisms by which fasting may provide benefits
  • Describe the appropriate medication adjustments in a patient who is participating in a fasting protocol

UAN: 0100-0000-19-065-L04-P/T

 

12:15PM - 1:15PM | NON-ACCREDITED EDUCATIONAL LUNCH

 

1:30PM - 2:30PM | BREAKOUT SESSION 1 AND 2:45PM - 3:45PM | BREAKOUT SESSION 4
Hyperinsulinemia, Insulin Resistance, and Targeted Medication and Lifestyle Interventions: Reframing Our Approach to Managing Type 2 Diabetes

Kendrick Murphy, PharmD, BCACP

Pharmacist learning objectives:

  • Illustrate the physiological effects of hyperinsulinemia and insulin resistance in the pathogenesis of type 2 diabetes
  • Explain the relationship between insulin and the medications used to treat type 2 diabetes in the context of hyper-insulinoma and insulin resistance
  • Summarize the evidence for low carbohydrate lifestyle interventions for people with type 2 diabetes
  • Recognize the appropriate management of pharmacotherapy for patients with type 2 diabetes when initiating and following a low carbohydrate lifestyle

Pharmacy Technician learning objectives:

  • Identify the effects of hyperinsulinemia resistance in type 2 diabetes
  • Recognize the evidence of low carbohydrate lifestyle interventions for people with type 2 diabetes
  • List medications used for patients with type 2 diabetes following a low carbohydrate lifestyle

UAN: 0100-0000-19-066-L01-P/T

 

1:30PM - 2:30PM | BREAKOUT SESSION 2 AND 2:45PM-3:45PM | BREAKOUT SESSION 5
Opportunities to Improve Antimicrobial Stewardship in Ambulatory Care Settings

Juan E. Villanueva, PharmD, BCPS, BCIDP; Alanna Rufe, PharmD, PGY2

Pharmacist/Pharmacy Technician learning objectives:

  • Describe proposed regulatory standards for antimicrobial stewardship in ambulatory care settings
  • Describe current trends in antibiotic prescribing in ambulatory care settings
  • Recognize appropriate antibiotic management to improve quality of care
  • Identify practical antimicrobial stewardship interventions to improve antibiotic prescribing

UAN: 0100-0000-19-067-L01-P/T

 

1:30PM - 2:30PM | BREAKOUT SESSION 3 AND 2:45PM - 3:45PM | BREAKOUT SESSION 6
Recognize, Respond, Revive: Live Naloxone Training

Rebekah Fettkether, PharmD; Morgan Karrels, Doctor of Pharmacy Candidate, 2020

Pharmacist learning objectives:

  • Recognize the importance of naloxone use in combating the opioid epidemic and the protections provided under the Good Samaritan Law
  • Identify signs and risk factors associated with opioid overdose
  • Describe how to appropriately respond to a suspected opioid overdose and demonstrate how to use naloxone to reverse an overdose
  • Compare/Contrast the different forms of naloxone administration

Pharmacy Technician learning objectives:

  • Recognize the importance of naloxone use in combating the opioid epidemic and the protections provided under the Good Samaritan Law
  • Identify signs and risk factors associated with opioid overdose
  • Describe the different forms of naloxone administration

UAN: 0100-0000-19-071-L01-P/T

 

4:00PM - 5:00PM | GENERAL SESSION IV
Hot Topics in Pharmacy (Legislation, USP, Technician Scope, Payment for Service)
Speaker: TBD

Pharmacist/Pharmacy Technician learning objectives:

  • Identify the legislative issues AzPA is pursuing in 2020
  • Discuss implications of recent and proposed regulations

UAN 0100-0000-20-008-L03-P/T

 

SUNDAY, FEBRUARY 23rd

6:30AM - 11:30AM | REGISTRATION DESK HOURS

 

7:00AM - 8:00AM | BREAKFAST SYMPOSIUM
Breakfast Symposium:  Az-ASHP Town Hall:  Legislation Impacting Health-System Pharmacy: recent, Upcoming and What's Needed
Christi Cumba Jen, PharmD, BCPS; Carol Rollins, PharmD, BCNSP, FASHP, FAzPA; Mindy Burnworth, PharmD, BCPS, FASHP, FAzPA; Christopher Edwards, PharmD.

Pharmacist/Pharmacy Technician learning objectives:

  • Identify at least two methods of moving a pharmacy practice initiative forward to the ASHP House of Delegates
  • Discuss the role of Arizona delegates to the ASHP House of Delegates
  • Discuss the potential impact of selected policies coming before the ASHP House of Delegates in June to the practice of pharmacy in Arizona and pharmacy personnel

UAN: 0100-0000-19-073-L03-P/T

 

8:00AM - 9:30AM | GENERAL SESSION IV
Arizona Law Update 2019-2020

Roger Morris, R.Ph., J.D.; Jennifer Piatt, J.D.

Pharmacist/Pharmacy Technician learning objectives:

  • Identify major developments in U.S. Pharmacy law and related fields
  • Describe the practical ramifications of proposed state and national legislative initiatives
  • Recognize emerging patterns that will broadly affect the healthcare profession and pharmacy practice

UAN: 0100-0000-19-068-L03-P/T

 

9:45AM - 10:45AM | GENERAL SESSION V
Substance-Related Use and Mental Health Disorders:  Update on National Trends Healthcare
Martha P. Fankhauser, MS Pharm, BCPP, FASHP, FAzPA

Pharmacist learning objectives:

  • Discuss the 2018 National Survey on Drug Use and Health (SAMHSA) for current trends in substance use, mental illness, and suicidal behaviors that impacts healthcare
  • Recognize changes in the use of heroin, prescription opioids, marijuana, and other illicit drugs by gender and age group
  • Describe common co-occurring substance use and mental disorders that require treatment and clinical support service
  • List suicide prevention services and how to refer patients for evaluation and treatment
  • Promote patient-centered care in providing

Pharmacy technician learning objectives:

  • Discuss the 2018 National Survey on Drug Use and Health (SAMHSA) for current trends in substance use, mental illness, and suicidal behaviors that impacts healthcare
  • Recognize changes in the use of heroin, prescription opioids, marijuana, and other illicit drugs by gender and age groups
  • Describe common co-occurring substance use and mental disorders that require treatment and clinical support services
  • List suicide prevention services and how to refer patients for evaluation and treatment

UAN 0100-0000-20-002-L08-P/T

 

11:00AM - 12:00PM | GENERAL SESSION VI
New Drug Update:  2020 Advances in Pharmacotherapy
Robert Lipsy, PharmD., BCACP, FASHP, FAzPA

Pharmacist learning objectives:

  • Identify the appropriate place in therapy for newly approved drugs
  • Advise patients on the major adverse drug reactions to recently approved therapies
  • Evaluate laboratory results to determine if dose adjustments are needed with newly approved drugs

Pharmacy Technician learning objectives:

  • Assist pharmacists in evaluating if a dose change is necessary by recognizing laboratory values that are out of the normal range
  • Refer patients to pharmacists for suspected adverse reactions of newly approved drugs
  • Correctly prepare newly approved prescriptions that require non-oral administration

UAN 0100-0000-19-070-L01-P/T

REGISTRATION FEES

FULL CONFERENCE

Regular Price | Member
Pharmacist: $220*
Technician/Associate: $120*
Student: $40*

Regular Price | Non-Member
Pharmacist: $270
Technician/Associate: $150
Student: $50

 

*Members save an extra 10% if you register for full conference registration before December 1st! 

 

Onsite Registration: Additional $20

 

ONE DAY

Member Prices 
Pharmacist: $120
Technician/Associate: $80
Student: $25

Non-Member Prices 
Pharmacist: $170
Technician/Associate: $110
Student: $35

CONTINUING EDUCATION

CE Hours: 11.00
CE Units: 1.100
Accreditations: “The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.”

ACPE Small

Hotel Accommodations

Marriott Tucson University Park Hotel
880 E. Second Street, Tucson, AZ 85719

Room Rate: $159/night

Call and request the AzPA Room Block.

tusmp-exterior-0001-hor-clsc

Provided in Partnership with

ashp-az-horizontal
Refund Policy

Refund and/or cancellation requests must be made in writing to the Arizona Pharmacy Association office. A cancellation request must be made at least fourteen calendar days prior to the scheduled program and will require a $100.00 fee. No refunds will be issued for cancellation requests made less than fourteen calendar days prior to the scheduled program. You must submit a written request to cancel by email, fax, or standard mail and confirm that AzPA has received the request. AzPA reserves the right to cancel any activity due to insufficient pre-registration or as determined by the Executive Director or CE Administrator. In this case, all individuals pre-registered are notified and issued a full refund. Registration fees cannot be re-allocated due to the multiple steps involved with processing CE Credits. Refund checks will be mailed fourteen business days after the conclusion of the meeting, if approved. For more information about refunds and/or cancellation requests please contact the Operations Director.